Clinical Trial

A Clinical Study of SHR-1701 Combined With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Siewert Type II Adenocarcinoma of the Esophagogastric Junction

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 26, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Evaluating the efficacy and safety of SHR-1701 combined with chemotherapy for the perioperative treatment of locally advanced resectable Siewert type II adenocarcinoma of the esophagogastric junction.
Trial Details
NCT Number NCT07607210
Lead Sponsor Hebei Medical University Fourth Hospital
Conditions Siewert Type II Adenocarcinoma of the Esophagogastric Junction
Enrollment 38 participants
Start Date 2026-06-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-26